Skip to main content

Share story

AI

EXL deploys AI pipeline to accelerate medical-claims review

EXL deploys AI pipeline to accelerate medical-claims review Image: Primary
EXL says its Medical IDP system has reduced medical-record review from days to hours while retaining human validation at critical stages. The AWS-hosted pipeline classifies documents, extracts information and assigns each field a confidence score; results below a configurable threshold go to human reviewers. EXL trained its insurance-focused language model on more than 13,500 records from nine years of claims operations and uses it for summarization, queries and reasoning. The system handles protected health information under AWS access controls, but the performance results come from EXL's internal benchmarking rather than independent testing.
Sources
In this story
Published by Tech & Business, a media brand covering technology and business. This story was sourced from AWS Machine Learning Blog and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
Security Infrastructure
Security Infrastructure

Ransomware attack halts trading on Nepal Stock Exchange

The Nepal Stock Exchange suspended all Monday trading after ransomware hit infrastructure hosting the trading systems of 72 brokerages. Data Hub detected the attack early that morning and kept affected systems offline while invest...

Security
Security

Gyazo breach exposed metadata for 490 million images

A breach at screenshot-sharing service Gyazo exposed nearly 24 million customer records and an additional 490 million image-metadata records, Infosecurity Magazine reported. Attackers exploited an upload-server vulnerability, gain...

AI Products
AI Products

Tech groups use residual-value guarantees to lower AI financing costs

Large technology companies are increasingly using residual-value guarantees to finance AI equipment off their balance sheets, the Financial Times reports. The guarantees apply the companies' credit strength to the hardware's futur...

Capital Products
Capital Products

Novadip raises €10.4 million to complete pivotal bone-graft trial

Belgian regenerative-medicine company Novadip Biosciences has closed a €10.4 million convertible financing led by New Science Ventures. The funding will support completion of an ongoing Phase 3 trial in the United States and Europ...